Enhanced design now features End-of-Life capability and longer life
PLANO, Texas, May 11 /PRNewswire/ -- EaglePicher Medical Power, LLC, a leading supplier of batteries for implantable medical devices, today announced the introduction of its enhanced Lithium Carbon Monofluoride (Li/CFx) battery technology with end-of-life capability superior to currently available products in the market. The technology includes a proprietary new Elective Replacement Indicator (ERI) / End of Life (EOL) Indicator to accurately predict battery depletion six months in advance, potentially requiring fewer replacement surgeries over time.
"This enhanced chemistry delivers several benefits - to device manufacturers, physicians and patients. In addition to the new end-of-life feature, this proprietary chemistry provides superior energy density for longer battery life," said Joe Marotta, vice president and general manager of EaglePicher Medical Power. "It gives us great pride to announce a technology that will help improve the lives of patients who rely on implantable medical devices."
The enhanced Li/CFx battery chemistry provides higher energy density for use in a variety of implantable applications including telemetry-capable pacemakers and ICDs, neurostimulation devices, drug pumps, body fluid pumps and monitors.
The new technology will be available in a number of configurations ranging from under 350 mAh to 10 Ah.
For more information about EaglePicher Medical Power and the new Li/CFx technology, please visit the company's exhibit (booth #1471) at this week's Heart Rhythm 2009 conference and exhibition in Boston.
About EaglePicher Medical Power
Headquartered in Plano, Texas, EaglePicher Medical Power, LLC is an EaglePicher company and a world-leading supplier of batteries to manufacturers of implantable medical devices. Products include batteries for cardio defibrillators, heart monitors, heart re-synchronizers and neuromodulation systems.
EaglePicher Medical Power, one of the few producers of implantable-grade batteries in the world to be certified ISO 13485, leads the industry in producing rechargeable lithium-ion batteries for implantable applications. Building upon the world-class technology heritage of parent EaglePicher, the company offers one of the broadest ranges of electrochemistries for implantable applications including lithium-ion, lithium manganese dioxide, lithium thionyl chloride and lithium carbon monofluoride.
|SOURCE EaglePicher Medical Power, LLC|
Copyright©2009 PR Newswire.
All rights reserved